Standard Ultrasound Guidance vs. New Needle-steering Device in Subclavian Venous Catheterization
NEEDLEVISIO2
Ultrasound-guided Subclavian Venous Catheterization. A Randomized, Single-blind, Controlled Superiority Trial Comparing Standard Ultrasound Guidance and a New Needle-steering Device
1 other identifier
interventional
124
1 country
1
Brief Summary
Up to two-thirds of intensive care unit patients require central venous catheterization for which ultrasound-guided placement is now recommended. In this context, the team performed a prospective randomized simulation trial on a mannequin ("reduced torso model"), to compare the standard ultrasound guidance technique with an ultrasound-guided technique assisted by a new needle-steering device. The preliminary results show a statistically significant improvement in subclavian venipuncture (shorter success time, fewer multiple skin punctures, fewer punctures of the posterior wall of the subclavian vein and needle redirection, greater comfort) and argue for a clinical trial to test the performance of this new device in situation with intensive care unit patients. The hypothesis is that the needle-steering device will result in a better success rate of subclavian venous cannulation, at first puncture, compared with the conventional ultrasound-guided technique.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 5, 2023
CompletedFirst Posted
Study publicly available on registry
September 22, 2023
CompletedStudy Start
First participant enrolled
January 16, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 26, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 26, 2025
CompletedFebruary 11, 2026
February 1, 2026
1.9 years
September 5, 2023
February 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Successful catheter insertion at first skin puncture: Control group
The main objective is to compare the success rate of subclavian venous cannulation at first puncture between the conventional ultrasound guidance technique and ultrasound guidance assisted by a needle-steering device. Successful subclavian venous cannulation (success is defined as catheter insertion at first skin puncture). YES/NO
Day 0
Successful catheter insertion at first skin puncture: Experimental group
The main objective is to compare the success rate of subclavian venous cannulation at first puncture between the conventional ultrasound guidance technique and ultrasound guidance assisted by a needle-steering device. Successful subclavian venous cannulation (success is defined as catheter insertion at first skin puncture). YES/NO
Day 0
Secondary Outcomes (20)
A. Number of skin punctures required before successful central venous catheterism: Control group
Day 0
A. Number of skin punctures required before successful central venous catheterism: Experimental group
Day 0
B. Complication rate. All causes, composite score: Control group
Day 0
B. Complication rate. All causes, composite score: Control group
Hour 24
B. Complication rate. All causes, composite score: Experimental group
Day 0
- +15 more secondary outcomes
Other Outcomes (16)
Gender
Day 0
Age
Day 0
Weight
Day 0
- +13 more other outcomes
Study Arms (2)
Standard ultrasound guidance for subclavian venipuncture
NO INTERVENTION62 patients undergoing the usual standard ultrasound guidance technique for subclavian venipuncture
Subclavian venipuncture using the needle-steering device
EXPERIMENTAL62 patients undergoing subclavian venipuncture using the needle-steering device
Interventions
1. Navigation software is implemented in an ultrasound machine. 2. A linear ultrasound probe (similar in appearance to a standard ultrasound probe) is used 3. Magnetization of the puncture needle after short introduction of the needle in a dedicated device. 4. Real time needle guidance on the ultrasound screen during the puncture.
Eligibility Criteria
You may qualify if:
- Any resuscitation patient requiring subclavian venous catheterization.
- Patients or representatives must have given free, informed consent and signed the consent form or patient included in an emergency situation
- Patients must be affiliated to/or beneficiary of a health insurance scheme.
- All patients must be adults (≥18 years of age).
You may not qualify if:
- Moribund patients
- Patients with severe primary or secondary hemostasis disorders (Pq \< 50 G/L or TP \< 30%, or INR \> 2).
- Patients with a PaO2/FiO2 ratio \< 100 mmHg in mechanically ventilated patients (invasive or non-invasive ventilation).
- Patients with a precarious or unstable respiratory status and significant risk of barotrauma
- Patients for whom it is difficult to visualize the subclavian veins bilaterally (left and right) during ultrasound pre-screening
- Patients with a malformation/deformity of the subclavian region (congenital or acquired: history of surgery/cervical trauma)
- Body mass index \< 15 kg/m² ou \> 40 kg/m²
- Local infection at the puncture site
- Thrombosis of the subclavian or axillary vein
- Patients participating in a category 1 defined RIPH involving subclavian central venous line placement.
- Patients under court protection, guardianship or curatorship.
- Pregnant, parturient or breastfeeding women.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de NIMES
Nîmes, 30029, France
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- The patient will be blinded to his or her assignment group. The primary endpoint and secondary endpoints A, D, G, H, will be collected by an assessor independent from the operator, during the central venous catheterization procedure. This assessor will not be blinded to the technique used.
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 5, 2023
First Posted
September 22, 2023
Study Start
January 16, 2024
Primary Completion
December 26, 2025
Study Completion
December 26, 2025
Last Updated
February 11, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
The analysis of the data will be carried out by the BESPIM service of the CHU of Nîmes. Within one year after the end of the research or its interruption, a final report will be established and signed by the sponsor and the investigator. This report will be made available to the competent authority. The sponsor will transmit the results of the research in the form of a summary of the final report to the CPP (Comité de Protection des Personnes) and, if necessary, to the ANSM within one year after the end of the research.